A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation.
D000328:Adult; D001201:Ascites / Q000150:complications; D001424:Bacterial Infections / Q000401:mortality; D001663:Bilirubin / Q000097:blood; D001927:Brain Diseases / Q000150:complications / Q000401:mortality; D048909:Diabetes Complications; D004932:Esophageal and Gastric Varices / Q000150:complications; D006333:Heart Failure / Q000401:mortality; D006470:Hemorrhage / Q000401:mortality; D006529:Hepatomegaly / Q000150:complications; D006801:Humans; D006971:Hypersplenism / Q000150:complications; D006975:Hypertension, Portal / Q000601:surgery*; D007565:Jaundice / Q000150:complications; D008103:Liver Cirrhosis / Q000150:complications / Q000401:mortality; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000150:complications; D011167:Portacaval Shunt, Surgical; D011517:Prothrombin Time; D012709:Serum Albumin; D013163:Splenomegaly / Q000150:complications
D012709:Serum Albumin; D001663:Bilirubin